Kestra Medical Technologies (KMTS) EBITDA Margin (2024 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly EBITDA Margin of 137.38% for Q2 2026, up 14238.0% year-over-year from N/an in Q2 2025, and up 2.98% quarter-over-quarter from 141.6% in Q1 2026.
Kestra Medical Technologies (KMTS) EBITDA Margin (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported EBITDA Margin for 3 consecutive years, with 137.38% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA Margin rose 14238.0% year-over-year to 137.38%; the TTM figure through Apr 2026 stood at 141.65% (up 3620.0% YoY), while the FY2026 annual figure was 141.64%, up 3620.0% from the prior year.
- EBITDA Margin advanced to 137.38% in Q2 2026 per KMTS's latest filing, from 141.6% in the prior quarter.
- Across five years, EBITDA Margin topped out at 130.07% in Q4 2024 and bottomed at 279.77% in Q2 2025.
- Historically, EBITDA Margin has averaged 170.27% across 3 years, with a median of 142.9% in 2024.
- Annual changes were most pronounced in 2025 — EBITDA Margin tumbled 7737 bps — and 2026, when it soared 14238 bps.
- Kestra Medical Technologies' EBITDA Margin stood at 130.07% in 2024, then decreased by 8 bps to 140.73% in 2025, then rose by 2 bps to 137.38% in 2026.
- Business Quant data shows KMTS's EBITDA Margin at 137.38% in Q2 2026, 141.6% in Q1 2026, and 140.73% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 130.04 Bn | 124.82 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 51.73 Bn | 50.87 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.41 Bn | 34.06 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.27 Bn | 31.80 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 28.23 Bn | 25.55 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 24.99 Bn | 24.55 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.29 Bn | 14.88 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.79 Bn | 14.66 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 7.33% |
| 10 | Kestra Medical Technologies | 1.49 Bn | 1.13 Bn | 15.68 Mn | -137.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -137.38% |
| Jan 31, 2026 | -141.60% |
| Oct 31, 2025 | -140.73% |
| Jul 31, 2025 | -149.08% |
| Apr 30, 2025 | -279.77% |
| Jan 31, 2025 | -136.52% |
| Oct 31, 2024 | -130.07% |
| Jul 31, 2024 | -144.19% |
| Apr 30, 2024 | -202.40% |
| Jan 31, 2024 | -240.98% |